July 29, 2016
Recommended Topic Related To:

Lamprene

"The U.S. Food and Drug Administration today approved the Intercept Blood System for plasma, the first pathogen reduction system for use by blood establishments in the preparation of plasma in order to reduce the risk of transfusion-transmitted in"...

A A A

Lamprene

PATIENT INFORMATION

Patients should be warned that Lamprene (clofazimine) may cause a discoloration of the skin from red to brownish-black, as well as discoloration of the conjunctivae, lacrimal fluid, sweat, sputum, urine, and feces. Patients should be advised that skin discoloration, although reversible, may take several months or years to disappear after the conclusion of therapy with Lamprene (clofazimine) .

Patients should be told to take Lamprene (clofazimine) with meals.

Last reviewed on RxList: 11/5/2008
This monograph has been modified to include the generic and brand name in many instances.

Additional Lamprene Information

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.